[go: up one dir, main page]

GB201814038D0 - Ilven therapy - Google Patents

Ilven therapy

Info

Publication number
GB201814038D0
GB201814038D0 GBGB1814038.4A GB201814038A GB201814038D0 GB 201814038 D0 GB201814038 D0 GB 201814038D0 GB 201814038 A GB201814038 A GB 201814038A GB 201814038 D0 GB201814038 D0 GB 201814038D0
Authority
GB
United Kingdom
Prior art keywords
ilven
therapy
ilven therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1814038.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB1814038.4A priority Critical patent/GB201814038D0/en
Publication of GB201814038D0 publication Critical patent/GB201814038D0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
GBGB1814038.4A 2018-08-29 2018-08-29 Ilven therapy Ceased GB201814038D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1814038.4A GB201814038D0 (en) 2018-08-29 2018-08-29 Ilven therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1814038.4A GB201814038D0 (en) 2018-08-29 2018-08-29 Ilven therapy

Publications (1)

Publication Number Publication Date
GB201814038D0 true GB201814038D0 (en) 2018-10-10

Family

ID=63715239

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1814038.4A Ceased GB201814038D0 (en) 2018-08-29 2018-08-29 Ilven therapy

Country Status (1)

Country Link
GB (1) GB201814038D0 (en)

Similar Documents

Publication Publication Date Title
SG11202104461XA (en) Therapeutic methods
IL277336A (en) Combination therapy
GB201804255D0 (en) Macrophage-based therapy
GB201707153D0 (en) Therapy
GB201719646D0 (en) Therapy
GB201708663D0 (en) Therapy
GB201900702D0 (en) Therapy
GB201819853D0 (en) Therapy
IL280729A (en) Combination therapy
IL279908A (en) Combination therapy
SG11202101518QA (en) Combination therapy
GB201817385D0 (en) Therapy
GB201818579D0 (en) New therapy
GB201814036D0 (en) New therapy
GB201820895D0 (en) Therapy
GB201814038D0 (en) Ilven therapy
GB201919036D0 (en) Therapy
GB201916983D0 (en) Therapy
GB201914848D0 (en) Therapy
GB201913797D0 (en) Therapy
GB201913785D0 (en) Therapy
GB201912524D0 (en) Therapy
GB201911948D0 (en) Therapy
GB201815579D0 (en) Combination therapy
GB201911064D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)